The syntrophins are a family of adapter proteins that bind numerous signaling proteins and link them to the dystrophin protein complex (DPC). All five syntrophins share a common domain structure: a PDZ domain (which binds signaling proteins), two PH domains and a C-terminal region unique to the syntrophins (the SU domain). Syntrophin-associated signaling proteins include ion and water channels, neuronal nitric oxide synthase (nNOS), protein and lipid kinases, transporters and G-protein coupled receptors. This proposal will focus on the regulation of nNOS and aquaporin-4 (AQP4) interaction with alpha-syntrophin in skeletal muscle. Recent studies have shown that nNOS is critically important to muscle function and health. Loss of nNOS increases the susceptibility of muscle to exercise-induced fatigue, perhaps due in part to defective vasoregulation. The goal of this proposal is to determine the molecular mechanisms that regulate the interaction of alpha-syntrophin with dystrophin (via the PH2-SU domains) and with nNOS and AQP4 (via the PH1-PDZ domains). Based on recent studies showing that phosphorylation/dephosphorylation of beta2-syntrophin regulates interaction with a key PDZ ligand, we propose a comprehensive approach to identify phosphorylation sites on alpha- syntrophin and determine if phosphorylation status regulates syntrophin binding to dystrophin and to its PDZ ligands. Mutants of alpha-syntrophin that mimic or prevent phosphorylation will be analyzed for interaction with dystrophin and nNOS biochemically and in cell culture. Ultimately, mutated alpha-syntrophins will be studied in vivo in transgenic mice. These studies include nNOS targeting and physiological function of skeletal muscle. New transgenic results demonstrate that the PH1 domain is important in the association of nNOS with the DPC and the sarcolemma. We will examine the role of phosphatidylinositol lipids and PH1 binding proteins in this regulatory mechanism. The DPC is capable of binding four syntrophins, thus forming a scaffold for functionally interdependent signaling proteins. Deciphering the role of phosphorylation and phosphatidylinositol binding in this process is essential to understanding the signaling function of the DPC and its role in muscle diseases.

Public Health Relevance

Syntrophins are a family of proteins that are part of the dystrophin complex. Abnormalities in the dystrophin complex cause many forms of muscular dystrophy, including Duchenne MD. Syntrophins are also involved in many other human diseases, including cardiac arrhythmia, brain edema cause by trauma or stroke, epilepsy, and diabetes. Our long term goal is to understand the function of the syntrophins in cell signaling and how abnormalities cause disease.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-MOSS-H (04))
Program Officer
Porter, John D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Yang, F; Xu, Q; Cheong, Y-K et al. (2014) Comparison of intensity-dependent inhibition of spinal wide-dynamic range neurons by dorsal column and peripheral nerve stimulation in a rat model of neuropathic pain. Eur J Pain 18:978-88
Neumeier, Markus; Krautbauer, Sabrina; Schmidhofer, Sandra et al. (2013) Adiponectin receptor 1 C-terminus interacts with PDZ-domain proteins such as syntrophins. Exp Mol Pathol 95:180-6
Cruz, Nancy F; Ball, Kelly K; Froehner, Stanley C et al. (2013) Regional registration of [6-(14)C]glucose metabolism during brain activation of *-syntrophin knockout mice. J Neurochem 125:247-59
Eilert-Olsen, Martine; Haj-Yasein, Nadia Nabil; Vindedal, Gry Fluge et al. (2012) Deletion of aquaporin-4 changes the perivascular glial protein scaffold without disrupting the brain endothelial barrier. Glia 60:432-40
Kim, Min Jeong; Froehner, Stanley C; Adams, Marvin E et al. (2011) ?-Syntrophin is required for the hepatocyte growth factor-induced migration of cultured myoblasts. Exp Cell Res 317:2914-24
Percival, Justin M; Adamo, Candace M; Beavo, Joseph A et al. (2011) Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy. Handb Exp Pharmacol :323-44
Lyssand, John S; Lee, Kyung-Soon; DeFino, Mia et al. (2011) Syntrophin isoforms play specific functional roles in the ýý1D-adrenergic receptor/DAPC signalosome. Biochem Biophys Res Commun 412:596-601
Migliati, Elton R; Amiry-Moghaddam, Mahmood; Froehner, Stanley C et al. (2010) Na(+)-K (+)-2Cl (-) cotransport inhibitor attenuates cerebral edema following experimental stroke via the perivascular pool of aquaporin-4. Neurocrit Care 13:123-31
Schubert, Sandra; Knoch, Klaus-Peter; Ouwendijk, Joke et al. (2010) ?2-Syntrophin is a Cdk5 substrate that restrains the motility of insulin secretory granules. PLoS One 5:e12929
Adams, Marvin E; Anderson, Kendra N E; Froehner, Stanley C (2010) The alpha-syntrophin PH and PDZ domains scaffold acetylcholine receptors, utrophin, and neuronal nitric oxide synthase at the neuromuscular junction. J Neurosci 30:11004-10

Showing the most recent 10 out of 36 publications